Rare diseases
Investigational molecules
Locations
Back to Spain155 clinical trials in Lugo, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients
SpainA Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer
SpainStudy on the Safety and Effectiveness of Fianlimab, Cemiplimab, and Chemotherapy in Adults with Resectable Non-Small Cell Lung Cancer
SpainStudy of Pembrolizumab for Patients with Recurrent, Platinum-Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
SpainStudy on Carboplatin, Paclitaxel, Bevacizumab, and Rucaparib for Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Patients
SpainStudy of TransCon TLR7/8 Agonist, TransCon IL-2 β/γ, and Pembrolizumab for Patients with Advanced Head and Neck Cancer
SpainStudy Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments
SpainStudy Comparing Dostarlimab and Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
SpainStudy on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin
SpainStudy of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
SpainStudy of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
SpainStudy Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on metastatic prostate cancer, breast cancer, and non-small cell lung cancer treatments. Studies evaluate innovative therapies including immunotherapy combinations and targeted treatments.
Multiple trials exploring both neoadjuvant and adjuvant treatment approaches to improve patient outcomes.
Clinical research examining treatments for advanced colon cancer, pancreatic adenocarcinoma, and urothelial cancer. Studies evaluate neoadjuvant chemotherapy effectiveness and novel drug combinations.
Focus on improving survival rates through optimized treatment sequences and combinations.
Innovative research in IgA nephropathy and related conditions. Studies evaluate new therapeutic agents and their combinations with existing treatments to improve patient outcomes.
Emphasis on developing targeted therapies for chronic kidney conditions and immune-mediated disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
